Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study
- 7 August 1992
- journal article
- Published by Elsevier in Brain Research
- Vol. 587 (2), 241-249
- https://doi.org/10.1016/0006-8993(92)91003-w
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the ratNeuropharmacology, 1990
- Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's DiseaseBasic & Clinical Pharmacology & Toxicology, 1990
- Analysis of serial measurements in medical research.BMJ, 1990
- Molecular cloning and characterization of rat liver catechol-O-methyltransferaseGene, 1990
- Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferaseLife Sciences, 1988
- Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the ratJournal of Neural Transmission, 1987
- Intracerebral dialysis: Direct evidence for the utility of 3-MT measurements as an index of dopamine releaseLife Sciences, 1987
- Guinea Pig Striatum as a Model of Human Dopamine Deamination: The Role of Monoamine Oxidase Isozyme Ratio, Localization, and Affinity for Substrate in Synaptic Dopamine MetabolismJournal of Neurochemistry, 1985
- Effects of Intrastriatal Kainic Acid Injection on [3H]Dopamine Metabolism in Rat Striatal Slices: Evidence for Postsynaptic Glial Cell Metabolism by Both the Type A and B Forms of Monoamine OxidaseJournal of Neurochemistry, 1983
- O-Methylation of Epinephrine and Other Catechols in vitro and in vivoScience, 1957